Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2018 · 10-Q
Revenue$13.60M$13.60M+143.3% vs Q3 2017 Net Income$3.30M$3.30MN/M vs Q3 2017 EPS Diluted$0.03$0.03N/M vs Q3 2017 Gross Profit$9,946,000+148.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,557,000+928.8% Free Cash Flowderived$4,416,000+897.0% Margins · derivedGross margin73.1%+1.6 pt vs Q3 2017
Operating margin25.9%+34.5 pt vs Q3 2017
Net margin24.2%+34.8 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 7, 2018 · 38 d after period end